As the crucial lipolytic enzyme synthesized and secreted by the pancreas, human pancreatic lipase (hPL) is a predominant anti-obesity target, responsible for the regulation of lipid digestion and absorption in vivo [8,9,10]. The gene discussed is PNLIP; the disease is obesity due to melanocortin 4 receptor deficiency.